HealthQuill Pharma
Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member nations during the two-day meeting starting in India today.
Drugs Health Pharma

Prevention, preparedness, response to top G20 health group agenda

HQ Team April 17, 2023: Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member.

Read More
US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.
Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.

Read More
SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk and immunocompromised patients.
Drugs Medical Pharma

SAB gets FDA fast track nod for experimental drug to treat influenza

HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk.

Read More
New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose, the FDA stated.
Drugs Health Medical Pharma

USFDA updates safety warnings for opioid treatment drugs 

HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.

Read More
Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid tumors.
Drugs Health Pharma

Canada’s Fusion gets FDA nod for drug tests to treat solid tumors

HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid.

Read More
Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its relapsing multiple sclerosis drug after it caused liver injuries.
Drugs Health Pharma

FDA applies brakes on Merck’s multiple sclerosis drug tests

HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its.

Read More
About 263 million children and young people worldwide are out of school, and achieving education for all by 2030 is "seriously off track," the UN stated. 
Climate Health Pharma

Pandemic, poverty keeping 260 million children out of school: UN

HQ Team April 12, 2023: About 263 million children and young people worldwide are out of school, and achieving education for all by.

Read More
A 56-year-old woman from China's Guangdong province died on March 16 after being infected with avian influenza, AH3N8, sparking the world's most populous nation to enforce control and preventive measures.
Drugs Health Pharma

Chinese woman dies of AH3N8 virus, WHO fears spread

HQ Team April 12, 2023: A 56-year-old woman from China’s Guangdong province died on March 16 after being infected with avian influenza, AH3N8,.

Read More
Astec LifeSciences, a subsidiary of Godrej Agrovet, opened its research and development centre in Rabale, Maharashtra, India, to expand into the contract development and manufacturing business in the chemical industry.
Drugs Medical Pharma

India’s Astec LifeSciences to tap contract development market

HQ Team April 11, 2023: Astec LifeSciences, a subsidiary of Godrej Agrovet, opened its research and development centre in Rabale, Maharashtra, India, to.

Read More
Scientists are close to developing a human treatment for nonalcoholic fatty liver after they successfully developed a compound tested in non-human primates.
Drugs Health Pharma

Cure for nonalcoholic fatty liver disease may be near: Scientists say

HQ Team April 11, 2023: Scientists are close to developing a human treatment for nonalcoholic fatty liver after successfully developing a compound tested.

Read More